SHENZHEN, China, Nov. 1, 2023 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring System (CGM) brand, is delighted to announce that it has received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, facilitating the distribution and utilization of this game-changing technology throughout the European market..

中国深圳，2023年11月1日/PRNewswire/-SIBIONICS，世界第三大连续血糖监测系统（CGM）品牌，很高兴地宣布它因其革命性的GS1 CGM而获得CE标志。这个重要的里程碑标志着西伯利亚的重大成就，促进了这种改变游戏规则的技术在整个欧洲市场的分销和利用。。

The CE Mark, also known as the 'Conformité Européene' or European Conformity, is a certification that confirms a product's compliance with European Union (EU) health and safety standards, serving as proof of the products' quality, safety, and efficacy.

CE标志也称为“ConformitéEuropéene”或欧洲合规性，是确认产品符合欧盟（EU）健康和安全标准的认证，可作为产品质量，安全性和有效性的证据。

Founded in 2015, SIBIONICS boasts a workforce exceeding 700 individuals, with over 40% actively engaged in research and development efforts. To date, SIBIONICS has collaborated with 1,600 hospitals on integrating the GS1 CGM for inpatient treatment, benefiting over 600,000 users worldwide in managing their diabetes.

西伯利亚成立于2015年，拥有超过700人的劳动力，超过40%的人积极参与研发工作。迄今为止，SIBIONICS已与1600家医院合作，整合GS1 CGM进行住院治疗，使全球60多万用户受益于管理糖尿病。

With an annual production capacity of 6,000,000 units and consistently achieving a low MARD value of 8.83% in each batch, SIBIONICS is well-equipped to serve a larger customer base..

年产量达60万台，每批产品的MARD值始终保持在8.83%的低水平，SIBIONICS拥有完善的设备，为更大的客户群提供服务。。

At its core, the SIBIONICS GS1 CGM System is designed to empower both healthcare professionals and patients with the information needed to make informed treatment decisions and maintain optimal glucose control.

SIBIONICS GS1 CGM系统的核心是为医疗保健专业人员和患者提供所需信息，以便做出明智的治疗决策并保持最佳的血糖控制。

The SIBIONICS GS1 CGM offers users 14 days of calibration-free continuous glucose monitoring solution, empowering them with the capability to transmit glucose data to their monitoring devices or mobile applications and generate professional AGP reports. To assist users in better diabetes management, the GS1 CGM also facilitates data sharing with friends and family while seamlessly integrates the latest ProView remote access platform.

SIBIONICS GS1 CGM为用户提供14天无校准连续葡萄糖监测解决方案，使他们能够将葡萄糖数据传输到他们的监测设备或移动应用程序，并生成专业的AGP报告。为了帮助用户更好地管理糖尿病，GS1 CGM还促进了与朋友和家人的数据共享，同时无缝集成了最新的ProView远程访问平台。

This equips healthcare providers with the ability to monitor remotely and deliver timely medical interventions as needed..

这使医疗保健提供者能够远程监控并根据需要及时提供医疗干预措施。。

As an innovative MedTech company that combines medical technology with artificial intelligence, SIBIONICS is committed to extending their innovative and groundbreaking diabetes management technology and expertise to more diabetes patients worldwide.

作为一家将医疗技术与人工智能相结合的创新MedTech公司，SIBIONICS致力于将其创新和开创性的糖尿病管理技术和专业知识扩展到全球更多的糖尿病患者。

Simultaneously, SIBIONICS is vigorously expanding its presence in various specialized segments within the area of health management. Their successful launch of the consumer-grade biowearable - the KS1 Continuous Ketone Monitoring System(CKM), has garnered enthusiastic acclaim from consumers.

同时，西伯利亚正在积极扩大其在卫生管理领域各专业领域的存在。他们成功推出了消费级生物可穿戴设备-KS1连续酮监测系统（CKM），引起了消费者的热烈好评。

Starting today, SIBIONICS GS1 CGM products will gradually become available for pre-sales in EU countries, the UK, and other European countries. Those interested can find more information on official website at www.sibionicscgm.com.

从今天开始，SIBIONICS GS1 CGM产品将逐渐在欧盟国家，英国和其他欧洲国家销售。有兴趣的人可以在www.sibionicscgm.com的官方网站上找到更多信息。

Contact

联系

Sandra Zhang

张先生

zy.zhang@sibionics.com

zy.zhang@sibionics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/sibionics-achieves-milestone-receiving-ce-mark-for-its-groundbreaking-gs1-continuous-glucose-monitoring-system-301974051.html

查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/sibionics-achieves-milestone-receiving-ce-mark-for-its-groundbreaking-gs1-continuous-glucose-monitoring-system-301974051.html

SOURCE SIBIONICS

源SIBIONICS